Y, X., J, W., X, Z., J, L., Q, L., G, L., . . . J, G. (2022). Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation. Frontiers in pharmacology, 13, 862618. https://doi.org/10.3389/fphar.2022.862618
Chicago Style (17th ed.) CitationY, Xuan, et al. "Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation." Frontiers in Pharmacology 13 (2022): 862618. https://doi.org/10.3389/fphar.2022.862618.
MLA (9th ed.) CitationY, Xuan, et al. "Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation." Frontiers in Pharmacology, vol. 13, 2022, p. 862618, https://doi.org/10.3389/fphar.2022.862618.